Morena Shaw

Morena Shaw has nearly 20 years of experience supporting both large and small molecule drug development. Specialties include Translational and Nonclinical Pharmacology, MABEL dosing strategies, Bioanalytics and IND GAP analysis. She has years of experience developing immunomodulatory monoclonal antibody therapies to support innovative clinical trial design and analysis as well as regulatory filings. Before transitioning to large molecule pharmacology, Morena contributed to RTK, GPCR, transporter, and enzyme target small molecule therapeutic programs at Pfizer Global Research and Development and Janssen Pharmaceuticals. Morena is a native San Diegan who did her graduate and undergraduate studies at UCSD.